CVA Family Office’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-130
Closed -$5.48K 1007
2023
Q2
$5.48K Hold
130
﹤0.01% 794
2023
Q1
$4.63K Buy
+130
New +$4.72K ﹤0.01% 785
2022
Q2
Sell
-40
Closed -$3K 1013
2022
Q1
$3K Hold
40
﹤0.01% 853
2021
Q4
$4K Buy
+40
New +$3.84K ﹤0.01% 789
2021
Q3
Sell
-40
Closed -$4K 936
2021
Q2
$4K Buy
+40
New +$3.38K ﹤0.01% 816

Other funds holding SYNH

CVA Family Office's SYNH Position: Q3 2023 in Review

CVA Family Office sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 130 shares — an estimated $5.48K sold.

CVA Family Office first reported a position in SYNH in Q2 2021 and held it in 5 quarters. The position peaked at $5.48K in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • CVA Family Office reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • CVA Family Office sold 130 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $5.48K.
  • CVA Family Office first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and held it in 5 quarters.
  • CVA Family Office's Syneos Health, Inc. Class A Common Stock position peaked at $5.48K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on CVA Family Office's 13F filing for Q3 2023, filed 11 Oct 2023.